Garazi Aldanondo
Overview
Explore the profile of Garazi Aldanondo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Passannante R, Gomez-Vallejo V, Sagartzazu-Aizpurua M, Vignau Arsuaga L, Marco-Moreno P, Aldanondo G, et al.
Biomedicines
. 2023 Feb;
11(2).
PMID: 36830793
Background And Objective: The determination of pharmacokinetic properties of new chemical entities is a key step in the process of drug development. Positron emission tomography (PET) is an ideal technique...
2.
Aizpurua J, Miranda J, Irastorza A, Torres E, Eceiza M, Sagartzazu-Aizpurua M, et al.
Eur J Med Chem
. 2021 Jan;
213:113160.
PMID: 33493827
The hypothesis of rescuing FKBP12/RyR1 interaction and intracellular calcium homeostasis through molecular "reshaping" of FKBP12 was investigated. To this end, novel 4-arylthioalkyl-1-carboxyalkyl-1,2,3-triazoles were designed and synthesized, and their efficacy was...
3.
Filareto A, Maguire-Nguyen K, Gan Q, Aldanondo G, Machado L, Chamberlain J, et al.
Proc Natl Acad Sci U S A
. 2018 Jul;
115(30):7741-7746.
PMID: 29987034
Duchenne muscular dystrophy (DMD) is a rare, muscle degenerative disease resulting from the absence of the dystrophin protein. DMD is characterized by progressive loss of muscle fibers, muscle weakness, and...
4.
Gil-Bea F, Aldanondo G, Lasa-Fernandez H, de Munain A, Vallejo-Illarramendi A
Expert Rev Mol Med
. 2017 Jun;
19:e7.
PMID: 28597807
Amyotrophic lateral sclerosis (ALS) is a severe neuromuscular disease characterised by a progressive loss of motor neurons that usually results in paralysis and death within 2 to 5 years after...
5.
Toral-Ojeda I, Aldanondo G, Lasa-Elgarresta J, Lasa-Fernandez H, Fernandez-Torron R, de Munain A, et al.
Expert Rev Mol Med
. 2016 Apr;
18:e7.
PMID: 27055500
Limb-girdle muscular dystrophy type 2A (LGMD2A) is a form of muscular dystrophy caused by mutations in calpain 3 (CAPN3). Several studies have implicated Ca2+ dysregulation as an underlying event in...
6.
Vallejo-Illarramendi A, Toral-Ojeda I, Aldanondo G, de Munain A
Expert Rev Mol Med
. 2014 Oct;
16:e16.
PMID: 25293420
Muscular dystrophies are a group of diseases characterised by the primary wasting of skeletal muscle, which compromises patient mobility and in the most severe cases originate a complete paralysis and...